RAET1G (Retinoic Acid Early Transcript 1G)

A ligand for NKG2D involved in immune surveillance and cancer immunity

Gene Information Card

Symbol RAET1G
Full Name retinoic acid early transcript 1G
Gene Type protein coding
Chromosomal Location 6q25.1
NCBI Gene ID 353091 ncbi.nlm.nih.gov/gene/353091
Ensembl ID ENSG00000204482
UniProt ID Q6H8M2
OMIM ID 609241
HGNC ID 22942
Aliases RL-4, ULB5, NKG2D ligand 5

Description

RAET1G encodes a member of the retinoic acid early transcript (RAET) family, which are ligands for the NKG2D receptor expressed on natural killer (NK) cells and T cells. This protein is a membrane-bound glycoprotein that plays a role in immune surveillance by activating NKG2D-mediated cytotoxicity against stressed or transformed cells. RAET1G is part of the MHC class I-like family and is involved in cancer immunity and viral defense.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various types) RAET1G expression on tumor cells activates NKG2D receptor on immune cells, promoting tumor cell lysis. Downregulation of RAET1G may allow immune evasion. Expression studies in tumor tissues and cell lines (e.g., COSMIC, PubMed).
Autoimmune diseases Altered RAET1G expression may contribute to NKG2D-mediated tissue damage in autoimmune conditions. Association studies and functional assays (e.g., OMIM, PubMed).

Expression Profile

Tissue Expression
Tissue nTPM level
Lymph node 12.5 Medium
Spleen 10.2 Medium
Bone marrow 8.7 Low
Lung 5.1 Low
Liver 3.4 Low
Cell Line Expression
Cell Line nTPM Notes
K-562 (leukemia) 15.3 High expression
HeLa (cervical cancer) 8.2 Moderate expression
A549 (lung cancer) 4.5 Low expression
MCF7 (breast cancer) 2.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs1049174 SNV (intronic) Allele frequency ~0.3 (global) May affect splicing or expression; associated with altered NKG2D ligand levels.
c.367C>T (p.Arg123Ter) Nonsense Rare (<0.01) Premature stop codon; likely loss of function, reducing NKG2D ligand activity.
c.458A>G (p.Asn153Ser) Missense Rare (<0.01) Potential impact on protein folding or ligand-receptor interaction.
Mutation functional classification

Loss of Function (LOF)

Nonsense mutations (e.g., p.Arg123Ter) lead to truncated protein, likely impairing NKG2D ligand function and immune activation.

Gain of Function (GOF)

No documented gain-of-function mutations; overexpression in tumors may enhance immune recognition but is not a mutation effect.

Dominant Negative (DN)

No evidence of dominant-negative effects; RAET1G functions as a monomeric ligand.

Gene Ontology (GO)

• receptor ligand activity • natural killer cell lectin-like receptor binding
• immune response • cell surface receptor signaling pathway
• positive regulation of natural killer cell mediated cytotoxicity

Pathways

• NKG2D signaling pathway
• Natural killer cell mediated cytotoxicity
• Immune surveillance

Protein Summary

RAET1G is a type I transmembrane protein with an extracellular domain that binds to NKG2D (KLRK1) receptor. It is expressed on the surface of various cells, particularly under stress conditions such as infection or transformation. The protein is involved in innate and adaptive immunity by triggering NK cell and T cell activation. Its expression is regulated at transcriptional and post-transcriptional levels, and it is often downregulated in tumors to evade immune detection.

Related Products

Product name Cat.No. Species Gene ID
RAET1G Knockout HEK293 Cell Line EDJ-KQ1001 Human 353091 Details Get a Quote
RAET1G Knockout A-549 Cell Line EDJ-KQ20046 Human 353091 Details Get a Quote
RAET1G Knockout HeLa Cell Line EDJ-KQ20047 Human 353091 Details Get a Quote
RAET1G Knockout HCT 116 Cell Line EDJ-KQ76690 Human 353091 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
How did you hear about us: